Oncology
Multiple Advanced Tumors After PD-1 Therapy Failure
0
Pipeline Programs↗
1
Active Trials↗
0
Companies Involved↗
Multiple Advanced Tumors After PD-1 Therapy Failure is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
1
clinical trials
Not yet recruiting1 · 100%
Clinical Trials
Trial Activity
Ivonescimab (PD-1/VEGF Bispecific Antibody) Plus Radiofrequency Ablation for Multiple Advanced Tumors After PD-1 Therapy Failure
Not yet recruiting·—·Phase 2·NCT07095803·60 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)